MRK - What's Going On With Medical Therapeutic Firm Aethlon Medical On Friday? | Benzinga
Friday, Aethlon Medical Inc (NASDAQ:AEMD) released results from an in vitro binding study of its Hemopurifier in removing extracellular vesicles (EVs) from plasma. Extracellular vesicles contribute to inflammation.
The translational study provides preclinical evidence to support Aethlon’s planned phase 1 safety, feasibility, and dose-finding clinical trials of the Hemopurifier in patients with solid tumors who have stable or progressive ...